Kurum Yazarı "Başaran, Özcan" Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed İçin Listeleme
-
How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study
Başaran, Özcan; Doğan, Volkan; Mert, Kadir Uğur; Özlek, Bülent; Özlek, Eda; Çelik, Oğuzhan; Biteker, Murat (Turkish Society of Cardiology, 2023)Background: The recent 2019 European Society of Cardiology/European Atherosclerosis Society practice guidelines introduced a new risk categorization for patients with diabetes. We aimed to compare the implications of the ... -
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
Başaran, Özcan; Doğan, Volkan; Beton, Osman; Tekinalp, Mehmet; Aykan, Ahmet Çagrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Springer, 2017)The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ... -
Inappropriate Use of Aspirin in Real-Life Cardiology Practice: Results from the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) Study
Çelik, Oğuzhan; Çil, Cem; Başaran, Özcan; Demirci, Erkan; Tanık, Veysel Ozan; Altuntaş, Emine; Sancar, Kadriye Memiç; Örsçelik, Özcan; Yetim, Mücahit (AVES, 2021)Background: Indications and appropriateness of aspirin use have not been well investigated in Turkey. Aims: To investigate the prescription patterns and appropriateness of aspirin in a real-world clinical setting. Study ... -
Increased Epicardial Fat Thickness Correlates with Aortic Stiffness and N-Terminal Pro-Brain Natriuretic Peptide Levels in Acute Ischemic Stroke Patients
Altun, İbrahim; Ünal, Yasemin; Başaran, Özcan; Akın, Fatih; Emir, Gülser Karadaban; Kutlu, Gülnihal; Biteker, Murat (Texas Heart Inst, 2016)Epicardial fat, a metabolically active tissue, has emerged as a risk factor and active player in metabolic and cardiovascular diseases. We investigated epicardial fat thickness in patients who had sustained an acute ischemic ... -
Is it time to abandon Friedewald formula? New equations for LDL-C calculation
Başaran, Özcan (THE TURKISH SOCIETY OF CARDIOLOGY, 2021)There is a causal relationship between cumulative low density lipoprotein cholesterol (LDL-C) arterial burden and atherosclerosis.[ -
Knowledge And Attitude Towards Hypertriglyceridemia Among Turkish Cardiologists
Ozdogan, O.; Başaran, Özcan; Gungor, B.; Sinan, U. Y. (Elsevier Ireland Ltd, 2019)The aim of this survey was to evaluate cardiologists’ knowledge and attitude towards hypertriglyceridemia and residual risk in Turkey -
Knowledge and attitudes towards hypertriglyceridaemia and associated residual risk amongst cardiologists in Turkey
Özdoǧan, Öner; Başaran, Özcan; Güngör, Barış Doruk L.D.A.L.; Sinan, Ümit Yaşar; Kayıkçıoğlu, Meral (Edizioni Minerva Medica, 2021)BACKGROUND: Hypertriglyceridemia (HTG) is an important component of residual risk. The knowledge regarding its treatment might not be at a desired level which might prevent patients from receiving the maximum benefit. We ... -
LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY
Başaran, Özcan; Doğan, Volkan; Biteker, Murat; Mert, K. U.; Özlek, Bülent; Çelik, O.; Kayıkçıoğlu, M. (Elsevier Ireland Ltd, 2019)[No abstract available] -
Management of LDL-cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real life evidence of Under-treatment from the EPHESUS registry
Mert, Kadir Uğur; Başaran, Özcan; Mert, Gurbet Özge; Doğan, Volkan; Rencüzoğulları, İbrahim; Özlek, Bülent; Cinier, Göksel; Şenol, Utku; Çelik, Oğuzhan; Özlek, Eda; Özdemir, İbrahim Halil; Özpamuk Karadeniz, Fatma; Bekar, Lütfü; Aktaş, Müjdat (Wiley, 2021)Background and aims Effective treatment of high low‐density lipoprotein cholesterol (LDL‐C) levels has been shown to improve cardiovascular outcomes of patients with diabetes mellitus (DM). Herein, we aimed to provide ... -
Metoprolol vs ivabradine in patients with mitral stenosis
Ergün, Gökhan; Doğan, Volkan; Başaran, Özcan; Biteker, Murat (Elsevier Ireland Ltd, 2016)[No abstract available] -
Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
Başaran, Özcan; Doğan, Volkan; Şahin, Cem; Biteker, Murat (Elsevier Ireland Ltd, 2016)Letter to Editor -
Obesity and atrial fibrillation
Ergün, Gökhan; Başaran, Özcan; Doğan, Volkan; Doğan, Marwa Mouline; Biteker, Murat (Elsevier Ireland Ltd, 2016)Letter to Editor -
Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?
Başaran, Özcan; Peker, Yüksel; Akdeniz, Bahri; Altay, Servet; Balcan, Baran (Turkish Society of Cardiology, 2023)Obstructive sleep apnea is common in adults with cardiovascular disease. Accumulating evidence suggests an association between obstructive sleep apnea and cardiovascular disease independent of the traditionally recognized ... -
Prediction of atrial fibrillation risk in the community
Biteker, Murat; Başaran, Özcan; Doğan, Volkan (Elsevier Ireland Ltd, 2016)Letter to editor -
PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)
Başaran, Özcan; Başaran, Nesrin Filiz; Çekic, Edip Güvenç; Altun, İbrahim; Doğan, Volkan; Mert, Gurbet Özge; Biteker, Murat (Sage Publications Inc, 2017)Introduction: Inappropriate use of oral anticoagulants (OACs) have not been well investigatedand, however, may be frequent in real-world practice in patients with nonvalvular atrial fibrillation (NVAF). This study was ... -
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
Başaran, Özcan; Doğan, Volkan; Sancar, Kadriye Memic; Altun, İbrahim; Mert, Kadir Ugur; Mert, Gurbet Ozge; Biteker, Murat (Turkish Soc Cardiology, 2016)Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ... -
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
Başaran, Özcan; Beton, Osman; Doğan, Volkan; Tekinalp, Mehmet; Aykan, Ahmet Çağrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Turkish Soc Cardiology, 2016)Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ... -
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
Biteker, Murat; Başaran, Özcan; Doğan, Volkan; Beton, O.; Tekinalp, M.; Aykan, Ahmet Çağrı; Kırma, C. (Wiley, 2016)What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ... -
Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study
Biteker, Murat; Başaran, Özcan; Doğan, Volkan; Altun, İbrahim; Karadeniz, Fatma Özpamuk; Tekkesin, Ahmet İlker; Bozyel, Serdar (Wiley, 2017)ObjectivesTo compare the clinical characteristics of and use of oral anticoagulant (OAC) therapy in individuals aged 80 and older with atrial fibrillation (AF) with those of individuals younger than 80 with AF in clinical ...